Fluor Daniel chosen by Warner-Lambert in Europe
Irvine, CA
Fluor Daniel has been awarded a $265 million contract to renovate and expand selected Warner-Lambert pharmaceutical facilities in Europe. The program will include a renovated and new bulk pharmaceutical manufacturing capacity, a 400,000-square-foot tableting and finishing facility and new support utilities. The project is on a fast-track schedule, with all facilities scheduled to be fully qualified in June 1999. Design and support services are being provided by Fluor Daniel offices in Marlton, NJ; Camberley, England; and county Cork, Ireland. — SES